Table 5. Incidence and CHR, AHR for cancer among the sampled patients, according to cancer type, during 8-year followed up period.
| Presence of cancer | Total(n=4,161) | HF with Digoxin(n=1,219) | HF with Non-Digoxin(n=2,942) |
|---|---|---|---|
| Lung Cancer (n,%) | 125, 3.00% | 42, 3.45% | 83, 2.82% |
| Incidence per 100 person-years | 1.54 | 1.75 | 1.46 |
| CHRa (95% CI) | − | 1.38(1.11–1.7)* | 1.00 |
| AHRb (95% CI) | − | 1.21(0.98–1.50) | 1.00 |
| Breast Cancer (n,%) | 30, 0.72% | 8, 0.66% | 22, 0.75% |
| Incidence per 100 person-years | 1.43 | 1.44 | 1.43 |
| CHRa (95% CI) | − | 1.47(1.18–1.83)** | 1.00 |
| AHRb (95% CI) | − | 1.30(1.05–1.62)* | 1.00 |
| Liver Cancer (n,%) | 97, 2.33% | 34, 2.79% | 63, 2.14% |
| Incidence per 100 person-years | 1.49 | 1.61 | 1.42 |
| CHRa (95% CI) | − | 1.46(1.17–1.83)** | 1.00 |
| AHRb (95% CI) | − | 1.29(1.03–1.62)* | 1.00 |
| Colorectal Cancer (n,%) | 149, 3.58% | 43, 3.53% | 106, 3.60% |
| Incidence per 100 person-years | 1.57 | 1.67 | 1.54 |
| CHRa (95% CI) | − | 1.13(0.80–1.62) | 1.00 |
| AHRb (95% CI) | − | 1.01(0.70–1.44) | 1.00 |
| Prostate Cancer (n,%) | 59, 1.42% | 14, 1.15% | 45, 1.53% |
| Incidence per 100 person-years | 1.63 | 1.55 | 1.66 |
| CHRa (95% CI) | − | 0.85(0.47–1.55) | 1.00 |
| AHRb (95% CI) | − | 0.75(0.41–1.37) | 1.00 |
| Gynecology Cancer (n,%) | 34, 0.82% | 14, 1.15% | 20,0.68% |
| Incidence per 100 person-years | 1.85 | 2.26 | 1.65 |
| CHRa (95% CI) | − | 1.87(0.94–3.70) | 1.00 |
| AHRb (95% CI) | − | 2.01(1.02–4.20) | 1.00 |
| Bladder Cancer (n,%) | 32, 0.77% | 8, 0.66% | 24, 0.82% |
| Incidence per 100 person-years | 1.48 | 1.65 | 1.44 |
| CHRa (95% CI) | − | 0.95(0.42–2.11) | 1.00 |
| AHRb (95% CI) | − | 0.82(0.37–1.84) | 1.00 |
| Kidney Cancer (n,%) | 30, 0.72% | 5, 0.41% | 25, 0.85% |
| Incidence per 100 person-years | 1.52 | 1.87 | 1.46 |
| CHRa (95% CI) | − | 0.55(0.21–1.45) | 1.00 |
| AHRb (95% CI) | − | 0.47(0.18–1.24) | 1.00 |
| Oral Cancer (n,%) | 18, 0.43% | 5, 0.41% | 13, 0.44% |
| Incidence per 100 person-years | 1.39 | 1.33 | 1.42 |
| CHRa (95% CI) | − | 1.13(0.40–3.18) | 1.00 |
| AHRb (95% CI) | − | 1.12(0.39–3.18) | 1.00 |
| Other Cancer (n,%) | 672, 16.15% | 195, 16.00% | 477, 16.21% |
| Incidence per 100 person-years | 1.62 | 1.78 | 1.56 |
| CHRa (95% CI) | − | 1.14(0.96–1.35) | 1.00 |
| AHRb (95% CI) | − | 1.03(0.87–1.21) | 1.00 |
aCHR: Crude hazard ratio was calculated by using stratified Cox proportional hazards regression, HF: Heart Failure
b.AHR (adjusted hazard ratio): Controlling the variables of age, gender, income, region, urbanization, cci, *: p<0.05 **: p<0.001
ICD-9-code: Prostate Cancer:185 Liver Cancer:155 Gynecology Cancer:180.182.183 Breast Cancer:174 Lung Cancer:162 Colorectal Cancer:153.154 Oral Cancer:145.141 Bladder Cancer:188 Kidney Cancer:189 Gall bladder Cancer:156